Fever of Unknown Origin


Fever of unknown origin ( FUO ) is a diagnostic dilemma for pediatricians because it is often difficult to distinguish clinically between benign and potentially life-threatening causes. Pediatricians face the important challenge of not missing the diagnosis of a serious illness or an easily treatable condition that can result in increased morbidity. Fortunately, FUO is usually an uncommon presentation of a common disease, with most of these common diseases being easily treatable.

The classification of FUO is best reserved for children with a temperature >38°C (100.4°F) documented by a healthcare provider and for which the cause could not be identified after at least 8 days of evaluation ( Table 204.1 ). It is important to differentiate FUO from fever without a source ; FWS is fever where the source has not yet been identified and is differentiated from FUO by the duration of the fever. FWS can progress to FUO if no cause is elicited after 7 days of evaluation.

Table 204.1
Summary of Definitions and Major Features of 4 Subtypes of Fever of Unknown Origin (FUO)
Adapted from Mackowak PA, Durack DT: Fever of unknown origin. In Mandell GL, Bennett, JE, Dolin R, editors: Mandell, Douglas, and Bennett's principles and practice of infectious diseases , ed 7, Philadelphia, 2010, Elsevier (Table 51-1).
FEATURE CLASSIC FUO HEALTHCARE-ASSOCIATED FUO IMMUNE-DEFICIENT FUO HIV-RELATED FUO
Definition >38°C (100.4°F), >3 wk, >2 visits or 1 wk in hospital ≥38°C (100.4°F), >1 wk, not present or incubating on admission ≥38°C (100.4°F), >1 wk, negative cultures after 48 hr ≥38°C (100.4°F), >3 wk for outpatients, >1 wk for inpatients, HIV infection confirmed
Patient location Community, clinic, or hospital Acute care hospital Hospital or clinic Community, clinic, or hospital
Leading causes Cancer, infections, inflammatory conditions, undiagnosed, habitual hyperthermia Healthcare-associated infections, postoperative complications, drug fever Majority caused by infections, but cause documented in only 40–60% HIV itself, typical and atypical mycobacteria, CMV, lymphomas, toxoplasmosis, cryptococcosis, immune reconstitution inflammatory syndrome (IRIS)
History emphasis Travel, contacts, animal and insect exposure, medications, immunizations, family history, cardiac valve disorder Operations and procedures, devices, anatomic considerations, drug treatment Stage of chemotherapy, drugs administered, underlying immunosuppressive disorder Drugs, exposures, risk factors, travel, contacts, stage of HIV infection
Examination emphasis Fundi, oropharynx, temporal artery, abdomen, lymph nodes, spleen, joints, skin, nails, genitalia, rectum or prostate, lower-limb deep veins Wounds, drains, devices, sinuses, urine Skin folds, IV sites, lungs, perianal area Mouth, sinuses, skin, lymph nodes, eyes, lungs, perianal area
Investigation emphasis Imaging, biopsies, sedimentation rate, skin tests Imaging, bacterial cultures CXR, bacterial cultures Blood and lymphocyte count; serologic tests; CXR; stool examination; biopsies of lung, bone marrow, and liver for cultures and cytologic tests; brain imaging
Management Observation, outpatient temperature chart, investigations, avoidance of empirical drug treatments Depends on situation Antimicrobial treatment protocols Antiviral and antimicrobial protocols, vaccines, revision of treatment regimens, good nutrition
Time course of disease Months Weeks Days Weeks to months
Tempo of investigation Weeks Days Hours Days to weeks
CMV, Cytomegalovirus; CXR, chest radiograph; HIV, human immunodeficiency virus; IV, intravenous line.

Etiology

The many causes of FUO in children are infectious, rheumatologic (connective tissue or autoimmune), autoinflammatory, oncologic, neurologic, genetic, factitious, and iatrogenic processes ( Table 204.2 ). Although oncologic disorders should be seriously considered, most children with malignancies do not have fever alone. The possibility of drug fever should be considered if the patient is receiving any drug. Drug fever is usually sustained and not associated with other symptoms. Discontinuation of the drug is associated with resolution of the fever, generally within 72 hr, although certain drugs, such as iodides, are excreted for a prolonged period, with fever that can persist for as long as 1 mo after drug withdrawal.

Table 204.2
Diagnostic Considerations for Fever of Unknown Origin in Children
ABSCESSES
  • Abdominal

  • Brain

  • Dental

  • Hepatic

  • Paraspinal

  • Pelvic

  • Perinephric

  • Rectal

  • Subphrenic

  • Psoas

BACTERIAL DISEASES
  • Actinomycosis

  • Bartonella henselae (cat-scratch disease)

  • Brucellosis

  • Campylobacter

  • Chlamydia

  • Francisella tularensis (tularemia)

  • Listeria monocytogenes (listeriosis)

  • Meningococcemia (chronic)

  • Mycoplasma pneumoniae

  • Rat-bite fever ( Streptobacillus moniliformis ; streptobacillary form of rat-bite fever)

  • Salmonella

  • Tuberculosis

  • Whipple disease

  • Yersiniosis

LOCALIZED INFECTIONS
  • Cholangitis

  • Infective endocarditis

  • Lymphogranuloma venereum

  • Mastoiditis

  • Osteomyelitis

  • Pneumonia

  • Pyelonephritis

  • Psittacosis

  • Sinusitis

SPIROCHETES
  • Borrelia burgdorferi (Lyme disease)

  • Relapsing fever (Borrelia recurrentis)

  • Leptospirosis

  • Rat-bite fever ( Spirillum minus ; spirillary form of rat-bite fever)

  • Syphilis

FUNGAL DISEASES
  • Blastomycosis (extrapulmonary)

  • Coccidioidomycosis (disseminated)

  • Histoplasmosis (disseminated)

RICKETTSIAE
  • African tick-bite fever

  • Ehrlichia canis

  • Q fever

  • Rocky Mountain spotted fever

  • Tick-borne typhus

VIRUSES
  • Cytomegalovirus

  • Hepatitis viruses

  • HIV

  • Epstein-Barr virus

PARASITIC DISEASES
  • Amebiasis

  • Babesiosis

  • Giardiasis

  • Malaria

  • Toxoplasmosis

  • Trichinosis

  • Trypanosomiasis

  • Visceral larva migrans ( Toxocara )

RHEUMATOLOGIC DISEASES
  • Behçet disease

  • Juvenile dermatomyositis

  • Juvenile idiopathic arthritis

  • Rheumatic fever

  • Systemic lupus erythematosus

HYPERSENSITIVITY DISEASES
  • Drug fever

  • Hypersensitivity pneumonitis

  • Serum sickness

  • Weber-Christian disease

NEOPLASMS
  • Atrial myxoma

  • Cholesterol granuloma

  • Hodgkin disease

  • Inflammatory pseudotumor

  • Leukemia

  • Lymphoma

  • Pheochromocytoma

  • Neuroblastoma

  • Wilms tumor

GRANULOMATOUS DISEASES
  • Granulomatosis with polyangiitis

  • Crohn disease

  • Granulomatous hepatitis

  • Sarcoidosis

FAMILIAL AND HEREDITARY DISEASES
  • Anhidrotic ectodermal dysplasia

  • Autonomic neuropathies

  • Fabry disease

  • Familial dysautonomia

  • Familial Hibernian fever

  • Familial Mediterranean fever, many other autoinflammatory diseases ( Chapter 188 )

  • Hypertriglyceridemia

  • Ichthyosis

  • Sickle cell crisis

  • Spinal cord/brain injury

MISCELLANEOUS
  • Addison disease

  • Castleman disease

  • Chronic active hepatitis

  • Cyclic neutropenia

  • Diabetes insipidus (central and nephrogenic)

  • Drug fever

  • Factitious fever

  • Hemophagocytic syndromes

  • Hypothalamic-central fever

  • Infantile cortical hyperostosis

  • Inflammatory bowel disease

  • Kawasaki disease

  • Kikuchi-Fujimoto disease

  • Metal fume fever

  • Pancreatitis

  • Periodic fever syndromes

  • Poisoning

  • Pulmonary embolism

  • Thrombophlebitis

  • Thyrotoxicosis, thyroiditis

Most fevers of unknown origin result from atypical presentations of common diseases. In some cases, the presentation as an FUO is characteristic of the disease (e.g., JIA), but the definitive diagnosis can be established only after prolonged observation, because initially there are no associated or specific findings on physical examination, and all laboratory results are negative or normal.

In the United States the systemic infectious diseases most commonly implicated in children with FUO are salmonellosis, tuberculosis, rickettsial diseases, syphilis, Lyme disease, cat-scratch disease, atypical prolonged presentations of common viral diseases, Epstein-Barr virus (EBV) infection, cytomegalovirus (CMV) infection, viral hepatitis, coccidioidomycosis, histoplasmosis, malaria, and toxoplasmosis. Less common infectious causes of FUO include tularemia, brucellosis, leptospirosis, and rat-bite fever. Acquired immunodeficiency syndrome alone is not usually responsible for FUO, although febrile illnesses often occur in patients with AIDS as a result of opportunistic infections (see Table 204.1 ).

Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are the connective tissue diseases most often associated with FUO. Inflammatory bowel disease (IBD) and Kawasaki disease are also frequently reported as causes of FUO. If factitious fever (inoculation of pyogenic material or manipulation of the thermometer by the patient or parent) is suspected, the presence and pattern of fever should be documented in the hospital. Prolonged and continuous observation of the patient, which can include electronic or video surveillance, is imperative. FUO lasting >6 mo is uncommon in children and suggests granulomatous, autoinflammatory, or autoimmune disease. Repeat interval evaluation is required, including history, physical examination, laboratory evaluation, and imaging studies.

Historically, 90% of pediatric FUO cases in the United States had an identifiable cause: approximately 50% infectious, 10–20% collagen vascular, and 10% oncologic. Later studies from the 1990s had variable results: 20–44% infectious, 0–7% collagen vascular, 2–3% oncologic, and up to 67% undiagnosed. The reason for the paradoxical increase in undiagnosed cases of FUO ironically is likely caused by improved infectious and autoimmune diagnostic techniques. The advent of polymerase chain reaction (PCR), improved culture techniques, and better understanding of atypical viral and bacterial pathogenesis and autoimmune processes likely contribute to earlier diagnosis of these conditions and fewer children with these conditions advancing to the category of FUO. By contrast, causes of FUO remain primarily infectious in developing settings where there is a higher infectious disease burden, and advanced diagnostics techniques are more limited.

Diagnosis

The evaluation of FUO requires a thorough history and physical examination supplemented by a few screening laboratory tests and additional laboratory and imaging evaluation informed by the history or abnormalities on examination or initial screening tests (see Table 204.2 ). Occasionally the fever pattern helps make a diagnosis ( Fig. 204.1 ). Nonetheless, most diseases causing an FUO do not have a typical fever pattern.

Fig. 204.1, Distinctive fever patterns.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here